FULVICIN Drug Patent Profile
✉ Email this page to a colleague
When do Fulvicin patents expire, and what generic alternatives are available?
Fulvicin is a drug marketed by Chartwell Rx and is included in two NDAs.
The generic ingredient in FULVICIN is griseofulvin, microsize. There is one drug master file entry for this compound. Seven suppliers are listed for this compound. Additional details are available on the griseofulvin, microsize profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for FULVICIN?
- What are the global sales for FULVICIN?
- What is Average Wholesale Price for FULVICIN?
Summary for FULVICIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| DailyMed Link: | FULVICIN at DailyMed |
US Patents and Regulatory Information for FULVICIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | FULVICIN P/G | griseofulvin, ultramicrosize | TABLET;ORAL | 061996-001 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Rx | FULVICIN P/G 330 | griseofulvin, ultramicrosize | TABLET;ORAL | 061996-004 | Apr 6, 1982 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Chartwell Rx | FULVICIN P/G | griseofulvin, ultramicrosize | TABLET;ORAL | 061996-002 | Approved Prior to Jan 1, 1982 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Chartwell Rx | FULVICIN P/G 165 | griseofulvin, ultramicrosize | TABLET;ORAL | 061996-003 | Apr 6, 1982 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
